Results 11 to 20 of about 13,106 (252)

Epidemiology of strongyloidiasis determined by parasite-specific IgG detections by enzyme-linked immunosorbent assay on urine samples using Strongyloides stercoralis, S. ratti and recombinant protein (NIE) as antigens in Northeast Thailand.

PLoS ONE, 2023
Detection of anti-Strongyloides IgG in urine by enzyme-linked immunosorbent assay (ELISA) for diagnosis of strongyloidiasis reportedly has comparable performance to conventional serum assays.
Chatanun Eamudomkarn, Sirowan Ruantip, Jiraporn Sithithaworn, Anchalee Techasen, Kulthida Y Kopoolrat, Chanika Worasith, Phattharaphon Wongphutorn, Jeffrey M Bethony, Thewarach Laha, Paiboon Sithithaworn   +9 more
doaj   +2 more sources

Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol

Pathogens, 2021
Strongyloidiasis affects an estimated 600 million people worldwide, especially in tropical and subtropical areas. Single-dose ivermectin treatment has shown to be effective among immunocompetent patients with uncomplicated strongyloidiasis.
Fernando Salvador, Ana Lucas-Dato, Silvia Roure, Marta Arsuaga, Asunción Pérez-Jacoiste, Magdalena García-Rodríguez, José A. Pérez-Molina, Dora Buonfrate, José María Saugar, Israel Molina   +9 more
doaj   +2 more sources

Strongyloidiasis in Ethiopia: systematic review on risk factors, diagnosis, prevalence and clinical outcomes

Infectious Diseases of Poverty, 2019
Background Strongyloidiasis is a gastrointestinal infection caused by the parasitic nematode Strongyloides stercoralis. It is estimated to infect up to 370 million people globally and is predominately found in tropical and subtropical areas of ...
Yitagele Terefe, Kirstin Ross, Harriet Whiley   +2 more
doaj   +2 more sources

Seroprevalence of <i>Strongyloides stercoralis</i> Infection and Its Risk Factors in Pregnant Women Referred to Al-Zahra Hospital in Guilan Province, North Part of Iran: A Cross-Sectional Study From 2024 to 2025. [PDF]

J Parasitol Res
Background In immunocompromised individuals, strongyloidiasis may progress to hyperinfection syndrome or disseminated disease. To date, the death of a pregnant woman infected with Strongyloides stercoralis has been reported. Chronic cases carry a risk of malnutrition, especially among vulnerable populations like pregnant women and children.
Sorouri Majd M, Kia EB, Sharami SH, Mohebali M, Jafari A, Latifi R, Fakhrieh-Kashan Z.   +6 more
europepmc   +2 more sources

Human strongyloidiasis: complexities and pathways forward

Clinical Microbiology Reviews, 2023
SUMMARY Strongyloidiasis is a World Health Organization neglected tropical disease usually caused by Strongyloides stercoralis, a parasitic worm with a complex life cycle.
D. Buonfrate, R. Bradbury, Matthew R. Watts, Z. Bisoffi   +3 more
semanticscholar   +1 more source

Diagnostic performance of Strongyloides-specific IgG4 detection in urine for diagnosis of human strongyloidiasis

Parasites & Vectors, 2023
Background Detection of parasite-specific IgG in urine is a sensitive method for diagnosis of strongyloidiasis and gives similar accuracy to serum IgG. However, there are no data concerning detection of IgG subclass in urine.
Phattharaphon Wongphutorn, Chanika Worasith, K. Kopolrat, Chutima Homwong, J. Sithithaworn, Chatanun Eamudomkarn, Anchalee Techasen, Patcharaporn Tippayawat, Opal Pitaksakurat, Nuttanan Hongsrichan, Thomas Crellen, P. Sithithaworn   +11 more
semanticscholar   +1 more source

Current pharmacotherapeutic strategies for Strongyloidiasis and the complications in its treatment

Expert Opinion on Pharmacotherapy, 2022
Introduction Strongyloidiasis, an infection caused by the soil-transmitted helminth Strongyloides stercoralis, can lead immunocompromised people to a life-threatening syndrome.
D. Buonfrate, P. Rodari, B. Barda, W. Page, L. Einsiedel, M. Watts   +5 more
semanticscholar   +1 more source

Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control.

Lancet. Infectious Diseases (Print), 2022
In 2020, WHO recognised the importance of strongyloidiasis alongside soil-transmitted helminths (STH) in their 2021-30 roadmap, which aspires to target Strongyloides stercoralis with preventive chemotherapy by use of ivermectin.
Javier Gandasegui, C. Onwuchekwa, A. Krolewiecki, S. Doyle, R. Pullan, W. Enbiale, S. Kepha, H-A Hatherell, L. van Lieshout, María Cambra-Pellejà, Valdemiro Escola, José Muñoz   +11 more
semanticscholar   +1 more source

Epidemiology, clinical features, and outcomes of strongyloidiasis in Taiwan from 1988 to 2020: A case series and literature review

Journal of Microbiology, Immunology and Infection, 2023
Objectives: We described a case of Strongyloides hyperinfection syndrome, reported a case series, and reviewed published cases of strongyloidiasis in Taiwan.
Yung-An Chen, Hong-Ming Hsu, Hsuan Wang, Hung-Hsue Lan, Sung-Hsi Huang, Chien-Ching Hung, Kua-Eyre Su   +6 more
doaj   +1 more source

Prevalence of Chagas disease and strongyloidiasis among HIV-infected Latin American immigrants in Italy - The CHILI study.

Travel Medicine and Infectious Disease, 2022
INTRODUCTION Screening HIV-positive migrants for neglected tropical diseases having potential for life-threatening reactivation, such as Chagas disease and strongyloidiasis is not widely implemented.
P. Rodari, F. Tamarozzi, S. Tais, M. Degani, F. Perandin, D. Buonfrate, E. Nicastri, L. Lepore, M. L. Giancola, S. Carrara, A. Tavelli, A. Cozzi-Lepri, A. d’Arminio Monforte, Ronaldo Silva, A. Angheben   +14 more
semanticscholar   +1 more source